We performed a multiplex gene expression analysis using the Nanostring nCounter GX Human Cancer Reference kit for PT5 with a HR−/HER2+ subtype, which revealed high expression of HIF1A and HER2/ERBB2 (nCounts >500) (Figure S3A). This evidence concerns the gene HIF1A and cancer.